
|Videos|October 11, 2016
Evidence and Outcomes in Atopic Dermatitis
Advertisement
Panelists Peter L. Salgo, MD; Jeffrey D. Dunn, PharmD, MBA; Ed Pezalla, MD, MPH; Jonathan Silverberg, MD, PhD, MPH; and Cheryl Allen, BS Pharm, MBA, provide insight on the evidence and outcomes in atopic dermatitis and how they impact coverage.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
November 2025 Pharmacy Policy Updates
2
Semaglutide Shows Direct Organ-Protective Benefits Beyond Weight Loss in HFpEF
3
Immune Synergy May Explain Why Some Patients Achieve Durable Remission With Cilta-Cel
4
Neladalkib Shows Durable Responses in Heavily Pretreated ALK-Positive Lung Cancer
5















































































































































































































